992 results on '"Yokota, Shumpei"'
Search Results
2. Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study
3. Retraction Note: Murine hypothalamic destruction with vascular cell apoptosis subsequent to combined administration of human papilloma virus vaccine and pertussis toxin
4. The Potential and Limits of Hematopoietic Stem Cell Transplantation for the Treatment of Autosomal Dominant Hyper-IgE Syndrome
5. Analysis of cases of severe respiratory failure in children with influenza (H1N1) 2009 infection in Japan
6. Murine hypothalamic destruction with vascular cell apoptosis subsequent to combined administration of human papilloma virus vaccine and pertussis toxin
7. Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan
8. A Pediatrician's Perspective on Environmental Hypersensitivity: Stress Intolerance in Children of School-Absenteeism, Focusing on the Similarities with Juvenile Fibromyalgia
9. Usefulness of two interferon-γ release assays for rheumatic disease
10. Flow cytometric chemosensitivity assay using JC-1, a sensor of mitochondrial transmembrane potential, in acute leukemia
11. Influence of pre-hydration and pharmacogenetics on plasma methotrexate concentration and renal dysfunction following high-dose methotrexate therapy
12. Prognostic Factors for Chronic Active Epstein-Barr Virus Infection
13. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis
14. Interleukin-6 inhibits early differentiation of ATDC5 chondrogenic progenitor cells
15. Chemo-sensitivity in a panel of B-cell precursor acute lymphoblastic leukemia cell lines, YCUB series, derived from children
16. Decreased serum osmolality promotes ductus arteriosus constriction
17. Radiologic analysis of the effect of tocilizumab on hands and large joints in children with systemic juvenile idiopathic arthritis
18. Guidance on the use of canakinumab in patients with cryopyrin-associated periodic syndrome in Japan
19. Clinical analysis of 50 children with juvenile dermatomyositis
20. Human parechovirus-3 infection in nine neonates and infants presenting symptoms of hemophagocytic lymphohistiocytosis
21. Efficacy, pharmacokinetics, and safety of adalimumab in pediatric patients with juvenile idiopathic arthritis in Japan
22. Safety and response to influenza vaccine in patients with systemic-onset juvenile idiopathic arthritis receiving tocilizumab
23. Safety and efficacy of long-term etanercept in the treatment of methotrexate-refractory polyarticular-course juvenile idiopathic arthritis in Japan
24. Definitive differences in laboratory and radiological characteristics between two subtypes of juvenile idiopathic arthritis: systemic arthritis and polyarthritis
25. Guidance on the use of adalimumab for juvenile idiopathic arthritis in Japan
26. Safety and efficacy of tocilizumab, an anti-IL-6-receptor monoclonal antibody, in patients with polyarticular-course juvenile idiopathic arthritis
27. Urinary ß2-microglobulin in very preterm neonates with chorioamnionitis
28. Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials
29. Association of IRF5 Polymorphisms with Susceptibility to Hemophagocytic Lymphohistiocytosis in Children
30. Guidance on using tocilizumab for juvenile idiopathic arthritis
31. Acquisition of expanded indications for intravenous cyclophosphamide in the management of childhood rheumatic disease in general
32. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
33. PET assessment of disease activity in children with juvenile idiopathic arthritis
34. Guidelines on the use of etanercept for juvenile idiopathic arthritis in Japan
35. Comparison of brachial artery flow-mediated dilation in youth with type 1 and type 2 diabetes mellitus
36. Cyclosporine for acute encephalopathy with biphasic seizures and late reduced diffusion
37. Suppressed neutrophil function in children with acute lymphoblastic leukemia
38. The role of heme oxygenase-1 in systemic-onset juvenile idiopathic arthritis
39. Methotrexate for the treatment of juvenile idiopathic arthritis: process to approval for JIA indication in Japan
40. Improvement of reduced serum cartilage oligomeric matrix protein levels in systemic juvenile idiopathic arthritis patients treated with the anti-interleukin-6 receptor monoclonal antibody tocilizumab
41. Hyper-IgD syndrome with novel mutation in a Japanese girl
42. Mizoribine for renal sarcoidosis: effective steroid tapering and prevention of recurrence
43. Cross-cultural adaptation and validation of the Japanese version of the Childhood Health Assessment Questionnaire (CHAQ)
44. Increased chemosensitivity and elevated reactive oxygen species are mediated by glutathione reduction in glutamine deprived neuroblastoma cells
45. Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology
46. Severity of respiratory signs and symptoms and virus profiles in Japanese children with acute respiratory illness
47. Long-term Follow-up of Busulfan, Etoposide, and Nimustine Hydrochloride (ACNU) or Melphalan as Conditioning Regimens for Childhood Acute Leukemia and Lymphoma
48. Proposal for juvenile idiopathic arthritis guidance on diagnosis and treatment for primary care pediatricians and nonpediatric rheumatologists (2007)
49. Amelioration of steroids and cyclosporine-resistant nephrotic syndrome by pravastatin
50. Intravenous gamma globulin for thrombotic microangiopathy of unknown etiology
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.